V0136479

House mark for a full line of pharmaceuticals (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); pharmaceutical preparations, namely, pharmaceutical preparations intended to treat prevalent diseases in humans, namely, cardiometabolic diseases, cardiovascular diseases, hypertension and obesity.

Scientific research, scientific research in the fields of pharmaceuticals and medicine; chemical and medical laboratories.